Her Strange Blisters Wouldn ’t Go Away. What Was It?
It started with a bout of dry, itchy skin. Soon everything hurt. A specialist found a way to find some relief. (Source: NYT Health)
Source: NYT Health - October 7, 2023 Category: Consumer Health News Authors: Lisa Sanders, M.D. Tags: Skin Steroids Tests (Medical) Autoimmune Diseases Antibodies Source Type: news
COVID-19 Tied to Autoimmune Disease Risk COVID-19 Tied to Autoimmune Disease Risk
Patients with more severe COVID-19 that required hospitalization in the ICU were more likely to develop vasculitis, alopecia totalis, and several other autoimmune conditions.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - October 6, 2023 Category: Allergy & Immunology Tags: Rheumatology News Source Type: news
Immunity-enhancing cocktail protects mice against multiple hospital germs
Some people in hospital die not from the illness or accident that got them admitted but from germs they catch once there. In the United States alone, there are hundreds of thousands of hospital-acquired infections each year, leading to tens of thousands of deaths. Seeking to lower this toll, researchers have now come up with an
immune-boosting cocktail that increases the survival
of mice exposed to the microbes responsible.
The three-compound formulation, which the researchers unusually refer to as a vaccine, provided up to 28 days of protection from the notorious hospital bacterium
Pseudomonas aerugin...
Source: ScienceNOW - October 4, 2023 Category: Science Source Type: news
The Mystery of My Burning Esophagus
As a science writer, I ’ve spent years covering the rise of allergic conditions. Why couldn’t I figure out my own? (Source: NYT Health)
Source: NYT Health - October 4, 2023 Category: Consumer Health News Authors: Moises Velasquez-Manoff Tags: Allergies Microbiology Autoimmune Diseases Throat Immune System Asthma Antidepressants Antibiotics Source Type: news
Self-Silencing Is Making Women Sick
“Be more disappointing” is not a piece of advice most people would pay money to hear, but in my therapy office, it’s often the most valuable guidance I can give. My clients are mostly women, and nearly all of them struggle with a fear of disappointing others. Our culture rewards women for being perpetually pleasant, self-sacrificing, and emotionally in control, and it can feel counterintuitive for my clients to say “no”—or firmly assert their wants and needs. But my work is about helping them realize that their health might literally depend on it.
[time-brightcove not-tgx=”trueR...
Source: TIME: Health - October 3, 2023 Category: Consumer Health News Authors: Maytal Eyal Tags: Uncategorized freelance Source Type: news
Roche to present new key clinical and real-world data at ECTRIMS-ACTRIMS 2023 showcasing strength of long-term outcomes in MS and NMOSD
Late-breaking results from Phase III trial of OCREVUS (ocrelizumab) subcutaneous injection and Phase II trial of BTK inhibitorfenebrutinib in multiple sclerosis (MS) will be presented10-year OCREVUS efficacy and safety data show significant benefit in slowing long-term disability progression and consistent long-term safety profile in MSAdditional OCREVUS real-world and clinical data show impact for underrepresented populations including more than 3,200 pregnant women and Black and Hispanic/Latinx patients with MSLonger-term safety data and late-breaking efficacy data from Phase III trial of ENSPRYNG (satralizumab) inneurom...
Source: Roche Media News - October 2, 2023 Category: Pharmaceuticals Source Type: news
Roche to present new key clinical and real-world data at ECTRIMS-ACTRIMS 2023 showcasing strength of long-term outcomes in MS and NMOSD
Late-breaking results from Phase III trial of OCREVUS (ocrelizumab) subcutaneous injection and Phase II trial of BTK inhibitorfenebrutinib in multiple sclerosis (MS) will be presented10-year OCREVUS efficacy and safety data show significant benefit in slowing long-term disability progression and consistent long-term safety profile in MSAdditional OCREVUS real-world and clinical data show impact for underrepresented populations including more than 3,200 pregnant women and Black and Hispanic/Latinx patients with MSLonger-term safety data and late-breaking efficacy data from Phase III trial of ENSPRYNG (satralizumab) inneurom...
Source: Roche Investor Update - October 2, 2023 Category: Pharmaceuticals Source Type: news
Histopathology of Cold Agglutinin Disease Histopathology of Cold Agglutinin Disease
Review the characteristics of cold agglutinin disease, a type of autoimmune hemolytic anemia characterized in recent years as a distinct B-cell lymphoproliferative disease.American Journal of Clinical Pathology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 29, 2023 Category: Consumer Health News Tags: Pathology & Lab Medicine Journal Article Source Type: news
Are Cellular Therapies the Future of Autoimmune Disease? Are Cellular Therapies the Future of Autoimmune Disease?
Promising results from small case studies and early clinical trials hint at the potential of CAR-T cell therapy to treat -- and possibly cure -- autoimmune diseases like lupus.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 27, 2023 Category: Consumer Health News Tags: Rheumatology News Source Type: news
Ginger May Ease Inflammation of Autoimmune Diseases
MONDAY, Sept. 25, 2023 -- Ginger supplements may help those with certain autoimmune diseases, such as lupus and rheumatoid arthritis, control inflammation.
New research has added evidence to support the impact of ginger on white blood cell function,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 25, 2023 Category: General Medicine Source Type: news
Ginger Consumption May Mitigate Neutrophil Dysfunction Ginger Consumption May Mitigate Neutrophil Dysfunction
An oral ginger extract was associated with reduced action of the neutrophil activity associated with the development of autoimmune and inflammatory diseases.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - September 22, 2023 Category: Allergy & Immunology Tags: Rheumatology News Source Type: news
European Commission Approves First Tocilizumab Biosimilar European Commission Approves First Tocilizumab Biosimilar
The biosimilar, commercially called Tyenne, is indicated to treat several autoimmune diseases as well as cytokine release syndrome and COVID-19.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - September 21, 2023 Category: Allergy & Immunology Tags: Rheumatology News Source Type: news
Mayo Clinic advances research on mysterious blood vessel disease
Immunofluorescent image of highly activated immune cells in giant cell arteritis (GCA). This inflammatory blood vessel condition is an autoimmune disease that affects about 200,000 people in the U.S. Giant cell arteritis (GCA), formerly known as temporal arteritis, was first described by Mayo doctors and classified as an inflammatory condition of the blood vessels in the early to mid-20th century. The condition causes bulging blood vessels at the temples, which, left untreated, may lead to… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - September 16, 2023 Category: Databases & Libraries Source Type: news
Pemphigus Vulgaris After the Second Dose of COVID-19 Vaccine Pemphigus Vulgaris After the Second Dose of COVID-19 Vaccine
This report details a case of new-onset pemphigus vulgaris, a potentially severe autoimmune blistering disease, after a series of COVID-19 vaccinations.Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 15, 2023 Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news
‘Theory of all matter’ physicists among 2023 Breakthrough prize winners
Immunologists behind pioneering cancer therapy also among recipients of most lucrative prize in scienceTwo physicists who played a key role in advancing a theory that describes the basis of all matter and a pair of immunologists who developed a pioneering cancer therapy that is currently being investigated as a treatment for autoimmune disease are among the winners of the most lucrative prize in science.Founded in 2012, the Breakthrough prize is the world ’s largest international science prize, with the winners of the five main awards – three in life sciences, one in fundamental physics, and one in mathematics – each...
Source: Guardian Unlimited Science - September 14, 2023 Category: Science Authors: Linda Geddes Science correspondent Tags: Science prizes Medical research Cancer Physics Source Type: news
